Skip to content

Clinical trials

Active, not recruiting Leukemia, Biphenotypic, Acute trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Biphenotypic, Acute Status: Active, not recruiting Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20151
20172
20193
20201
20214
20224
20236
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group4
Fred Hutchinson Cancer Center3
Center for International Blood and Marrow Transplant Research2
City of Hope Medical Center2
Federal Research Institute of Pediatric Hematology, Oncology and Immunology2
M.D. Anderson Cancer Center2
National Cancer Institute (NCI)2
Barbara Ann Karmanos Cancer Institute1
Johns Hopkins All Children's Hospital1
Kura Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Biphenotypic, Acute26
Leukemia, Myeloid, Acute17
Precursor Cell Lymphoblastic Leukemia-Lymphoma16
Myelodysplastic Syndromes12
Burkitt Lymphoma7
Lymphoma6
Leukemia5
Myeloproliferative Disorders5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma5
Leukemia, Lymphocytic, Chronic, B-Cell4

Trials

Showing 76 to 26 of 26. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.